These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 19018861)

  • 41. Efficacy of adjuvant interferon-alpha therapy following curative resection in renal cell carcinoma: before the molecular targeting therapy era.
    Kai F; Takayama T; Sugiyama T; Furuse H; Mugiya S; Ozono S
    Jpn J Clin Oncol; 2009 May; 39(5):310-4. PubMed ID: 19363055
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival in young patients with intermediate- / high-risk myelofibrosis: estimates derived from databases for non transplant patients.
    Siragusa S; Passamonti F; Cervantes F; Tefferi A
    Am J Hematol; 2009 Mar; 84(3):140-3. PubMed ID: 19123461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An interesting case of pachydermoperiostosis with idiopathic myelofibrosis associated with monosomy 22.
    Arikan S; Sen I; Bahceci M; Tuzcu A; Ayli M
    Int J Dermatol; 2009 Aug; 48(8):882-5. PubMed ID: 19659869
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A homozygous deletion of a normal variation locus in a patient with hearing loss from non-consanguineous parents.
    Knijnenburg J; Oberstein SA; Frei K; Lucas T; Gijsbers AC; Ruivenkamp CA; Tanke HJ; Szuhai K
    J Med Genet; 2009 Jun; 46(6):412-7. PubMed ID: 19246478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic relevance of cytogenetic abnormalities in primary myelofibrosis: comparison of recent reports from Japan, the Mayo Clinic and MD Anderson Cancer Center.
    Tefferi A
    Eur J Haematol; 2009 Oct; 83(4):290-1. PubMed ID: 19558507
    [No Abstract]   [Full Text] [Related]  

  • 46. In vitro activity of 20 agents in different prognostic subgroups of chronic lymphocytic leukemia--rolipram and prednisolone active in cells from patients with poor prognosis.
    Lindhagen E; Norberg M; Kanduri M; Tobin G; Säisänen L; Aberg M; Gustafsson MG; Sundström C; Rosenquist R; Aleskog A
    Eur J Haematol; 2009 Jul; 83(1):22-34. PubMed ID: 19245531
    [TBL] [Abstract][Full Text] [Related]  

  • 47. JAK2 inhibitors: not the next imatinib but researchers see other possibilities.
    Garber K
    J Natl Cancer Inst; 2009 Jul; 101(14):980-2. PubMed ID: 19584324
    [No Abstract]   [Full Text] [Related]  

  • 48. Molecular diagnosis of myeloproliferative neoplasms.
    Patnaik MM; Tefferi A
    Expert Rev Mol Diagn; 2009 Jul; 9(5):481-92. PubMed ID: 19580432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The management and outcome of four pregnancies in women with idiopathic myelofibrosis.
    Tulpule S; Bewley S; Robinson SE; Radia D; Nelson-Piercy C; Harrison CN
    Br J Haematol; 2008 Jul; 142(3):480-2. PubMed ID: 18492097
    [No Abstract]   [Full Text] [Related]  

  • 50. Repeated molecular testing in gliomas: a retrospective study of 53 cases.
    Mahajan D; Prayson RA
    Am J Clin Pathol; 2009 Jul; 132(1):118-24. PubMed ID: 19864242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A homozygous mutation in the ferrochelatase gene underlies erythropoietic protoporphyria associated with palmar keratoderma.
    Méndez M; Poblete-Gutiérrez P; Morán-Jiménez MJ; Rodriguez ME; Garrido-Astray MC; Fontanellas A; Frank J; de Salamanca RE
    Br J Dermatol; 2009 Jun; 160(6):1330-4. PubMed ID: 19298273
    [No Abstract]   [Full Text] [Related]  

  • 52. How do JAK2-inhibitors work in myelofibrosis: an alternative hypothesis.
    Vannucchi AM
    Leuk Res; 2009 Dec; 33(12):1581-3. PubMed ID: 19573914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relationship between p53 gene and chromosome 13q14 variations and prognosis in primary intestinal lymphoma].
    Feng LJ; Zhang GP; Xie M; Cao PF; Fu CY; Hu ZL; Dai M
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jul; 11(7):555-8. PubMed ID: 19650989
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary myelofibrosis.
    Tefferi A
    Cancer Treat Res; 2008; 142():29-49. PubMed ID: 18283781
    [No Abstract]   [Full Text] [Related]  

  • 55. Blood film features of primary myelofibrosis.
    Bain BJ
    Am J Hematol; 2009 Mar; 84(3):187. PubMed ID: 18980175
    [No Abstract]   [Full Text] [Related]  

  • 56. Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
    Hasselbalch HC; Holmström MO
    Semin Immunopathol; 2019 Jan; 41(1):5-19. PubMed ID: 30203226
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular responses and chromosomal aberrations in patients with polycythemia vera treated with peg-proline-interferon alpha-2b.
    Them NC; Bagienski K; Berg T; Gisslinger B; Schalling M; Chen D; Buxhofer-Ausch V; Thaler J; Schloegl E; Gastl GA; Wolf D; Strecker K; Egle A; Melchardt T; Burgstaller S; Willenbacher E; Zagrijtschuk O; Klade C; Greil R; Gisslinger H; Kralovics R
    Am J Hematol; 2015 Apr; 90(4):288-94. PubMed ID: 25545244
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complex patterns of chromosome 11 aberrations in myeloid malignancies target CBL, MLL, DDB1 and LMO2.
    Klampfl T; Milosevic JD; Puda A; Schönegger A; Bagienski K; Berg T; Harutyunyan AS; Gisslinger B; Rumi E; Malcovati L; Pietra D; Elena C; Della Porta MG; Pieri L; Guglielmelli P; Bock C; Doubek M; Dvorakova D; Suvajdzic N; Tomin D; Tosic N; Racil Z; Steurer M; Pavlovic S; Vannucchi AM; Cazzola M; Gisslinger H; Kralovics R
    PLoS One; 2013; 8(10):e77819. PubMed ID: 24147083
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic and epigenetic alterations of myeloproliferative disorders.
    Milosevic JD; Kralovics R
    Int J Hematol; 2013 Feb; 97(2):183-97. PubMed ID: 23233154
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms.
    Beer PA; Ortmann CA; Stegelmann F; Guglielmelli P; Reilly JT; Larsen TS; Hasselbalch HC; Vannucchi AM; Möller P; Döhner K; Green AR
    Haematologica; 2010 Dec; 95(12):2153-6. PubMed ID: 20823136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.